| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |